Walking a thin line: distinguishing between research and medical practice during Operation Desert Storm.
E J
EJ
Schuchardt
D001694:Biological Warfare; D001904:Botulinum Antitoxin / Q000627:therapeutic use; D002618:Chemical Warfare; D015507:Drugs, Investigational / Q000592:standards / Q000627:therapeutic use*; D004992:Ethics, Medical; D006077:Government Agencies; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D007493:Iraq; D016365:Liability, Legal; D008889:Military Personnel / Q000331:legislation & jurisprudence*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration